PAPER Rusanen M, Rovio S, Ngandu T, Nissinen A, Tuomilehto J, Soininen H, Kivipelto M
SEARCH RESULTS
329939 RESULTS
PAPER Albani D, Polito L, Signorini A, Forloni G
Neuroprotective properties of resveratrol in different neurodegenerative disorders.
Biofactors. 2010 Sep;36(5):370-6. PubMed: 20848560PAPER Merino-Serrais P, Knafo S, Alonso-Nanclares L, Fernaud-Espinosa I, Defelipe J
Layer-specific alterations to CA1 dendritic spines in a mouse model of Alzheimer's disease.
Hippocampus. 2011 Oct;21(10):1037-44. PubMed: 20848609PAPER Mani V, Parle M, Ramasamy K, Abdul Majeed AB
Reversal of memory deficits by Coriandrum sativum leaves in mice.
J Sci Food Agric. 2011 Jan 15;91(1):186-92. PubMed: 20848667PAPER Bartley M, O'Neill D
Working with early Alzheimer's disease.
Ir Med J. 2010 Jul-Aug;103(7):197-9. PubMed: 20848737PAPER Texel SJ, Mattson MP
Impaired adaptive cellular responses to oxidative stress and the pathogenesis of Alzheimer's disease.
Antioxid Redox Signal. 2011 Apr 15;14(8):1519-34. PubMed: 20849373PAPER Agüera-Ortiz L, Frank-García A, Gil P, Moreno A,
Clinical progression of moderate-to-severe Alzheimer's disease and caregiver burden: a 12-month multicenter prospective observational study.
Int Psychogeriatr. 2010 Dec;22(8):1265-79. PubMed: 20849672PAPER Herrmann N, Black SE, Li A, Lanctôt KL
Discontinuing cholinesterase inhibitors: results of a survey of Canadian dementia experts.
Int Psychogeriatr. 2011 May;23(4):539-45. PubMed: 20849673PAPER Takahashi H, Fukumoto H, Maeda R, Terauchi J, Kato K, Miyamoto M
Ameliorative effects of a non-competitive BACE1 inhibitor TAK-070 on Aβ peptide levels and impaired learning behavior in aged rats.
Brain Res. 2010 Nov 18;1361:146-56. PubMed: 20849831PAPER Fernandez JW, Rezai-Zadeh K, Obregon D, Tan J
EGCG functions through estrogen receptor-mediated activation of ADAM10 in the promotion of non-amyloidogenic processing of APP.
FEBS Lett. 2010 Oct 8;584(19):4259-67. PubMed: 20849853PAPER Talboom JS, Engler-Chiurazzi EB, Whiteaker P, Simard AR, Lukas R, Acosta JI, Prokai L, Bimonte-Nelson HA
A component of Premarin(®) enhances multiple cognitive functions and influences nicotinic receptor expression.
Horm Behav. 2010 Nov;58(5):917-28. PubMed: 20849857PAPER Benedict C, Frey WH, Schiöth HB, Schultes B, Born J, Hallschmid M
Intranasal insulin as a therapeutic option in the treatment of cognitive impairments.
Exp Gerontol. 2011 Feb-Mar;46(2-3):112-5. PubMed: 20849944PAPER Garelick MG, Kennedy BK
TOR on the brain.
Exp Gerontol. 2011 Feb-Mar;46(2-3):155-63. PubMed: 20849946PAPER Cohen E
Countering neurodegeneration by reducing the activity of the insulin/IGF signaling pathway: current knowledge and future prospects.
Exp Gerontol. 2011 Feb-Mar;46(2-3):124-8. PubMed: 20849948PAPER Silver M, Montana G, Nichols TE,
False positives in neuroimaging genetics using voxel-based morphometry data.
Neuroimage. 2011 Jan 15;54(2):992-1000. PubMed: 20849959Current Filters
No filters selected